Laser treatment versus eye drops for newly diagnosed glaucoma

This trial is testing whether a non-invasive laser treatment called selective laser trabeculoplasty works as well as—or better than—daily eye drops (latanoprost) for people newly diagnosed with glaucoma or ocular hypertension. Both treatments aim to lower the pressure inside your eye to prevent vision loss. The study will compare how well each approach controls eye pressure over time.

Glaucoma can lead to blindness if eye pressure isn't controlled, but doctors aren't certain whether starting with laser treatment or medication is more effective for newly diagnosed patients. This trial will help answer that question and give doctors and patients better information about the best first-line treatment choice.